Watchlist Manager

Watchlist

Price: 4 770 KRW -1.75% Market Closed

Market Cap: ₩100.9B

	Kukje Pharma Co Ltd KRX:002720	KR

Income Statement

Currency: KRW

	Mar-2006	Jun-2006	Sep-2006	Dec-2006	Mar-2007	Jun-2007	Sep-2007	Dec-2007	Mar-2008	Jun-2008	Sep-2008	Dec-2008	Mar-2009	Jun-2009	Sep-2009	Dec-2009	Mar-2010	Jun-2010	Sep-2010	Dec-2010	Mar-2011	Jun-2011	Sep-2011	Dec-2011	Mar-2012	Jun-2012	Sep-2012	Dec-2012	Mar-2013	Jun-2013	Sep-2013	Dec-2013	Mar-2014	Jun-2014	Sep-2014	Dec-2014	Mar-2015	Jun-2015	Sep-2015	Dec-2015	Mar-2016	Jun-2016	Sep-2016	Dec-2016	Mar-2017	Jun-2017	Sep-2017	Dec-2017	Mar-2018	Jun-2018	Sep-2018	Dec-2018	Mar-2019	Jun-2019	Sep-2019	Dec-2019	Mar-2020	Jun-2020	Sep-2020	Dec-2020	Mar-2021	Jun-2021	Sep-2021	Dec-2021	Mar-2022	Jun-2022	Sep-2022	Dec-2022	Mar-2023	Jun-2023	Sep-2023	Dec-2023	Mar-2024	Jun-2024	Sep-2024	Dec-2024	Mar-2025	Jun-2025	Sep-2025
Revenue
Interest Expense	1 150	1 107	1 066	1 049	1 019	1 042	1 078	1 094	1 097	1 088	1 143	1 393	1 673	1 849	1 959	1 910	1 835	0	0	0	0	0	0	1 394	433	0	842	1 653	0	0	735	1 398	1 035	1 387	1 395	1 379	1 381	1 372	1 360	1 367	1 353	1 329	1 268	1 189	1 099	1 025	990	888	857	847	834	901	914	935	929	863	830	756	656	650	622	616	663	696	737	800	883	1 000	1 139	1 264	1 369	1 440	1 450	1 407	1 322	1 206	0	0	0
Revenue	90 756 N/A	93 553 +3%	95 447 +2%	96 368 +1%	97 273 +1%	98 969 +2%	100 851 +2%	102 357 +1%	103 756 +1%	108 606 +5%	113 017 +4%	118 923 +5%	121 638 +2%	120 559 -1%	121 850 +1%	121 652 0%	122 565 +1%	125 048 +2%	125 623 +0%	129 304 +3%	132 046 +2%	128 789 -2%	129 919 +1%	104 857 -19%	143 287 +37%	146 564 +2%	144 117 -2%	126 768 -12%	118 167 -7%	115 836 -2%	113 963 -2%	120 461 +6%	120 462 +0%	121 533 +1%	123 261 +1%	122 426 -1%	123 038 +0%	123 755 +1%	119 233 -4%	117 637 -1%	116 753 -1%	117 331 +0%	120 507 +3%	120 684 +0%	120 529 0%	119 213 -1%	122 138 +2%	123 310 +1%	123 967 +1%	122 581 -1%	117 496 -4%	107 681 -8%	104 477 -3%	103 492 -1%	101 855 -2%	111 122 +9%	117 304 +6%	124 123 +6%	131 537 +6%	130 395 -1%	124 741 -4%	118 750 -5%	115 090 -3%	119 746 +4%	125 612 +5%	128 227 +2%	128 556 +0%	126 583 -2%	125 740 -1%	129 044 +3%	131 005 +2%	135 373 +3%	140 499 +4%	142 597 +1%	150 124 +5%	156 463 +4%	160 433 +3%	167 813 +5%	173 795 +4%
Gross Profit
Cost of Revenue	(40 492)	(41 622)	(41 311)	(40 620)	(39 840)	(40 588)	(42 111)	(44 108)	(46 034)	(48 629)	(51 575)	(53 466)	(54 052)	(54 630)	(57 088)	(59 557)	(62 438)	(65 973)	(68 335)	(71 622)	(73 541)	(72 867)	(72 837)	(60 064)	(80 758)	(85 771)	(86 476)	(82 361)	(78 867)	(75 170)	(73 715)	(72 688)	(74 390)	(75 771)	(75 198)	(75 260)	(72 446)	(69 751)	(67 330)	(64 861)	(65 055)	(65 365)	(66 616)	(66 903)	(66 632)	(66 678)	(69 819)	(71 839)	(74 108)	(74 439)	(70 176)	(58 872)	(54 195)	(51 313)	(49 655)	(58 136)	(59 864)	(61 731)	(65 776)	(65 590)	(65 140)	(64 090)	(61 433)	(65 275)	(66 071)	(66 670)	(67 040)	(63 329)	(64 017)	(64 858)	(65 818)	(68 148)	(69 243)	(70 006)	(72 070)	(73 968)	(75 634)	(77 832)	(79 976)
Gross Profit	50 265 N/A	51 931 +3%	54 136 +4%	55 748 +3%	57 433 +3%	58 379 +2%	58 740 +1%	58 249 -1%	57 722 -1%	61 814 +7%	64 930 +5%	70 473 +9%	67 586 -4%	65 928 -2%	64 761 -2%	62 094 -4%	60 127 -3%	59 075 -2%	57 288 -3%	57 683 +1%	58 505 +1%	55 923 -4%	57 083 +2%	44 793 -22%	62 529 +40%	60 794 -3%	57 642 -5%	44 407 -23%	39 302 -11%	40 667 +3%	40 248 -1%	47 773 +19%	46 072 -4%	45 762 -1%	48 063 +5%	47 167 -2%	50 590 +7%	54 002 +7%	51 902 -4%	52 776 +2%	51 698 -2%	51 966 +1%	53 891 +4%	53 781 0%	53 896 +0%	52 535 -3%	52 318 0%	51 471 -2%	49 860 -3%	48 141 -3%	47 320 -2%	48 809 +3%	50 282 +3%	52 180 +4%	52 201 +0%	52 985 +2%	57 441 +8%	62 393 +9%	65 762 +5%	64 805 -1%	59 600 -8%	54 659 -8%	53 655 -2%	54 470 +2%	59 541 +9%	61 557 +3%	61 516 0%	63 254 +3%	61 723 -2%	64 186 +4%	65 187 +2%	67 225 +3%	71 256 +6%	72 591 +2%	78 054 +8%	82 495 +6%	84 800 +3%	89 981 +6%	93 819 +4%
Operating Income
Operating Expenses	(39 824)	(40 892)	(42 137)	(42 857)	(44 121)	(44 701)	(45 329)	(46 188)	(45 039)	(47 264)	(48 885)	(50 945)	(53 713)	(53 955)	(53 703)	(52 279)	(51 380)	(50 095)	(48 301)	(51 028)	(48 854)	(47 245)	(50 146)	(42 198)	(61 888)	(66 089)	(64 657)	(59 115)	(50 992)	(46 785)	(46 612)	(46 546)	(45 982)	(46 294)	(46 254)	(48 589)	(50 420)	(52 548)	(52 180)	(50 678)	(49 392)	(50 690)	(50 818)	(49 812)	(50 842)	(48 033)	(48 347)	(48 907)	(48 519)	(46 499)	(44 973)	(45 522)	(45 114)	(46 130)	(46 483)	(47 415)	(48 378)	(53 499)	(56 795)	(58 764)	(58 440)	(54 526)	(53 975)	(56 146)	(59 294)	(59 994)	(60 023)	(57 982)	(58 273)	(60 848)	(65 846)	(69 214)	(71 119)	(73 199)	(73 711)	(75 793)	(79 191)	(81 548)	(85 148)
Selling, General & Administrative	(38 014)	(39 161)	(40 508)	(41 280)	(42 887)	(43 456)	(44 183)	(45 003)	(44 036)	(46 195)	(47 695)	(49 792)	(52 614)	(52 661)	(52 326)	(50 894)	(50 013)	(49 294)	(48 502)	(51 181)	(49 787)	(48 605)	(51 147)	(41 180)	(62 581)	(66 584)	(64 763)	(57 550)	(49 684)	(45 476)	(45 291)	(45 292)	(44 442)	(44 540)	(44 502)	(46 447)	(47 746)	(49 667)	(49 097)	(49 043)	(47 924)	(49 039)	(49 297)	(48 081)	(47 644)	(45 551)	(45 654)	(45 363)	(44 181)	(42 620)	(40 484)	(41 611)	(41 567)	(42 705)	(43 308)	(43 952)	(44 493)	(49 457)	(52 597)	(54 752)	(55 043)	(51 071)	(50 374)	(52 249)	(55 224)	(55 962)	(56 432)	(54 805)	(54 916)	(57 385)	(62 026)	(65 450)	(67 683)	(69 941)	(71 088)	(71 672)	(75 854)	(77 750)	(80 348)
Research & Development	(1 194)	(1 121)	(1 029)	(986)	(661)	(705)	(641)	(713)	(563)	(635)	(759)	(728)	(674)	(868)	(955)	(968)	(948)	0	0	(340)	0	0	0	(670)	0	0	0	(1 027)	0	0	0	(817)	(1 137)	0	0	(1 534)	(1 913)	(2 124)	(2 328)	(1 066)	(895)	(1 087)	(1 043)	(1 331)	(2 095)	(2 230)	(2 442)	(3 291)	(3 367)	(3 621)	(4 225)	(3 592)	(3 074)	(2 806)	(2 411)	(2 604)	(3 025)	(3 153)	(3 276)	(3 037)	(2 361)	(2 380)	(2 491)	(2 772)	(2 927)	(2 873)	(2 411)	(1 967)	(2 141)	(2 243)	(2 614)	(2 646)	(2 425)	(2 368)	(1 838)	(1 811)	(2 095)	(1 983)	(2 447)
Depreciation & Amortization	(616)	(608)	(599)	(591)	(573)	(540)	(505)	(470)	(440)	(435)	(432)	(427)	(425)	(426)	(422)	(417)	(419)	0	0	(226)	(468)	0	0	(348)	0	0	(143)	(537)	0	0	(293)	(438)	(403)	(552)	(550)	(608)	(590)	(585)	(584)	(569)	(574)	(565)	(479)	(399)	(326)	(253)	(252)	(254)	(255)	(261)	(268)	(320)	(475)	(620)	(763)	(858)	(857)	(887)	(920)	(974)	(1 034)	(1 073)	(1 108)	(1 125)	(1 143)	(1 159)	(1 181)	(1 209)	(1 217)	(1 220)	(1 206)	(1 118)	(1 011)	(889)	(785)	(738)	(713)	(705)	(689)
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(801)	201	719	1 401	1 360	1 001	0	693	495	249	0	(1 308)	(1 309)	(1 028)	0	0	(1 202)	(1 202)	0	(171)	(172)	(171)	0	0	0	0	0	(777)	0	0	0	(716)	3	4	0	0	0	0	0	(3)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(1 573)	(529)	(1 110)	(1 665)
Operating Income	10 441 N/A	11 039 +6%	11 998 +9%	12 891 +7%	13 312 +3%	13 680 +3%	13 411 -2%	12 061 -10%	12 683 +5%	12 713 +0%	12 558 -1%	14 514 +16%	13 873 -4%	11 976 -14%	11 060 -8%	9 816 -11%	8 747 -11%	8 980 +3%	8 987 +0%	6 655 -26%	9 651 +45%	8 678 -10%	6 936 -20%	2 596 -63%	640 -75%	(5 297) N/A	(7 016) -32%	(14 708) -110%	(11 692) +21%	(6 119) +48%	(6 364) -4%	1 227 N/A	90 -93%	(532) N/A	1 809 N/A	(1 423) N/A	172 N/A	1 456 +747%	(277) N/A	2 098 N/A	2 306 +10%	1 276 -45%	3 073 +141%	3 969 +29%	3 055 -23%	4 502 +47%	3 971 -12%	2 564 -35%	1 339 -48%	1 641 +23%	2 346 +43%	3 287 +40%	5 167 +57%	6 050 +17%	5 718 -5%	5 571 -3%	9 064 +63%	8 894 -2%	8 967 +1%	6 041 -33%	1 160 -81%	133 -89%	(319) N/A	(1 676) -425%	247 N/A	1 563 +533%	1 493 -5%	5 273 +253%	3 450 -35%	3 338 -3%	(658) N/A	(1 989) -202%	138 N/A	(607) N/A	4 343 N/A	6 702 +54%	5 608 -16%	8 433 +50%	8 670 +3%
Pre-Tax Income
Interest Income Expense	(655)	(658)	(512)	(615)	(701)	(635)	(740)	(778)	(1 189)	(1 204)	(1 689)	(2 180)	(2 463)	(2 290)	(1 719)	(1 392)	(793)	(1 032)	(1 410)	(1 526)	(1 926)	(1 897)	(1 905)	(1 396)	(1 741)	(1 667)	(1 475)	(1 359)	(1 368)	(1 331)	(1 387)	(1 510)	(1 461)	(1 457)	(1 398)	(1 353)	(1 344)	(826)	(813)	(992)	(1 011)	(1 401)	(1 999)	(1 427)	(1 288)	(1 317)	(418)	(436)	98	(203)	(394)	(686)	(1 097)	(588)	(401)	(672)	(298)	(526)	(859)	(1 064)	(1 245)	(998)	(578)	(52)	(147)	103	386	(336)	(465)	(871)	(1 411)	(860)	(832)	(794)	(964)	(269)	(267)	(510)	(35)
Non-Reccuring Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(170)	0	0	0	0	0	0	(250)	(776)	0	(1 191)	(894)	(721)	0	(629)	(675)	(318)	(320)	5	6	(47)	(57)	(57)	(57)	32	38	38	34	(4)	(2)	13	18	(476)	(473)	(488)	(491)	(1 867)	(1 868)	(1 870)	(1 868)	(26)	(22)	(27)	(28)
Gain/Loss on Disposition of Assets	(241)	(236)	(235)	(225)	(217)	(167)	(191)	(280)	(382)	(445)	(1 731)	(1 651)	(1 591)	(1 618)	(337)	(345)	(223)	0	0	(74)	0	0	0	(10)	0	0	0	(5)	0	0	(65)	(95)	(71)	2	0	73	86	(2)	6	(38)	(40)	(34)	(42)	(45)	(49)	(43)	156	191	175	189	(10)	(5)	0	1	1	14	14	103	104	244	247	145	145	(7)	(41)	(6)	(0)	14	46	274	318	290	304	107	61	103	88	34	31
Total Other Income	544	538	520	521	74	134	151	72	574	659	722	797	1 078	1 144	1 302	1 258	1 206	650	377	523	0	0	0	688	130	(129)	41	236	319	812	827	901	919	1 045	1 201	(2 803)	(2 917)	(3 033)	(3 300)	(2 750)	(2 772)	(2 946)	(2 986)	50	12	(226)	(83)	454	634	904	1 145	552	469	(4 183)	(4 443)	(4 744)	(4 828)	(178)	(11)	340	306	361	549	628	602	496	238	271	395	(4 859)	(4 868)	(2 254)	(2 208)	3 140	3 113	100	(24)	62	301
Pre-Tax Income	10 089 N/A	10 685 +6%	11 773 +10%	12 572 +7%	12 469 -1%	13 013 +4%	12 632 -3%	11 075 -12%	11 686 +6%	11 723 +0%	9 859 -16%	11 479 +16%	10 896 -5%	9 211 -15%	10 306 +12%	9 338 -9%	8 937 -4%	8 598 -4%	7 954 -7%	5 576 -30%	7 730 +39%	6 781 -12%	5 031 -26%	1 878 -63%	(971) N/A	(7 092) -630%	(8 449) -19%	(15 836) -87%	(12 740) +20%	(6 637) +48%	(6 987) -5%	522 N/A	(522) N/A	(943) -81%	1 612 N/A	(5 676) N/A	(4 003) +29%	(2 407) +40%	(4 385) -82%	(1 682) +62%	(1 517) +10%	(3 106) -105%	(2 205) +29%	1 770 N/A	1 729 -2%	1 725 0%	2 732 +58%	2 053 -25%	2 246 +9%	1 902 -15%	2 411 +27%	2 830 +17%	4 219 +49%	1 284 -70%	881 -31%	121 -86%	3 895 +3 119%	8 238 +112%	8 144 -1%	5 594 -31%	506 -91%	(321) N/A	(168) +48%	(1 110) -560%	660 N/A	2 170 +229%	2 135 -2%	4 745 +122%	2 953 -38%	(2 606) N/A	(7 111) -173%	(6 681) +6%	(4 467) +33%	(24) +99%	4 685 N/A	6 609 +41%	5 384 -19%	7 992 +48%	8 939 +12%
Net Income
Tax Provision	(4 929)	(5 253)	(5 796)	(6 206)	(6 325)	(6 415)	(6 215)	(5 620)	(5 461)	(5 102)	(3 918)	(4 454)	(4 292)	(3 595)	(3 262)	(2 470)	(2 078)	(2 359)	(2 897)	(2 394)	(3 451)	(3 004)	(2 518)	(908)	(334)	(1 775)	(1 566)	(3 104)	(3 621)	(1 825)	(1 616)	1 150	1 027	947	703	(1 241)	(1 421)	(1 806)	(1 697)	(4 203)	(4 380)	(4 064)	(4 463)	(972)	(813)	(629)	(593)	(1 014)	(957)	(1 225)	(1 330)	(647)	(996)	(4 713)	(4 733)	(4 883)	(5 782)	(2 725)	(2 806)	(3 399)	(2 357)	(1 706)	(1 714)	(446)	(928)	(1 385)	(700)	(1 202)	(719)	(2 608)	(2 151)	(1 734)	(2 027)	397	(566)	(1 403)	(1 074)	(1 617)	(1 801)
Income from Continuing Operations	5 160	5 432	5 977	6 366	6 144	6 598	6 417	5 455	6 225	6 621	5 941	7 026	6 604	5 617	7 045	6 867	6 859	6 238	5 056	3 182	4 279	3 777	2 513	970	(1 306)	(8 868)	(10 016)	(18 940)	(16 362)	(8 463)	(8 604)	1 672	505	5	2 317	(6 917)	(5 422)	(4 212)	(6 082)	(5 884)	(5 898)	(7 171)	(6 669)	799	916	1 096	2 139	1 039	1 289	677	1 081	2 183	3 223	(3 429)	(3 852)	(4 762)	(1 888)	5 512	5 338	2 195	(1 850)	(2 026)	(1 883)	(1 556)	(269)	784	1 435	3 543	2 234	(5 214)	(9 261)	(8 415)	(6 495)	373	4 119	5 206	4 310	6 375	7 138
Income to Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(40)	0	0	(42)	(12)	(12)	(35)	0	59	68	236	453	404	405	277	(15)	23	30	(35)	(58)	(54)	(135)	(88)	(26)	(61)	37	49	54	50	19	11	10	10	7	3	1	(1)	(4)	5	8	4	6	(1)	(3)	4	11	11	15	11	5	2	(0)	(5)	(9)	(11)	(1)	(0)	(1)	(1)
Net Income (Common)	5 160 N/A	5 432 +5%	5 977 +10%	6 366 +7%	6 144 -3%	6 598 +7%	6 417 -3%	5 455 -15%	6 225 +14%	6 621 +6%	5 941 -10%	7 026 +18%	6 604 -6%	5 617 -15%	7 045 +25%	6 867 -3%	6 859 0%	6 238 -9%	5 056 -19%	3 182 -37%	4 240 +33%	3 738 -12%	2 474 -34%	928 -62%	(1 360) N/A	(8 922) -556%	(10 093) -13%	(18 940) -88%	(16 302) +14%	(8 394) +49%	(8 368) +0%	2 125 N/A	908 -57%	408 -55%	2 593 +536%	(6 932) N/A	(5 400) +22%	(4 183) +23%	(6 118) -46%	(5 943) +3%	(5 952) 0%	(7 304) -23%	(6 755) +8%	773 N/A	857 +11%	1 134 +32%	2 189 +93%	1 092 -50%	1 339 +23%	696 -48%	1 092 +57%	2 193 +101%	3 232 +47%	(3 423) N/A	(3 850) -12%	(4 761) -24%	(1 889) +60%	5 508 N/A	5 342 -3%	2 203 -59%	(1 846) N/A	(2 019) -9%	(1 882) +7%	(1 559) +17%	(265) +83%	795 N/A	1 446 +82%	3 557 +146%	2 244 -37%	(5 209) N/A	(9 259) -78%	(8 415) +9%	(6 499) +23%	363 N/A	4 108 +1 030%	5 205 +27%	4 310 -17%	6 374 +48%	7 137 +12%
EPS (Diluted)	303.52 N/A	319.52 +5%	351.58 +10%	374.47 +7%	361.41 -3%	388.11 +7%	356.5 -8%	320.88 -10%	366.17 +14%	389.47 +6%	349.47 -10%	413.29 +18%	388.47 -6%	330.41 -15%	414.41 +25%	403.94 -3%	403.47 0%	346.55 -14%	280.88 -19%	187.17 -33%	249.41 +33%	207.66 -17%	137.44 -34%	51.55 -62%	-75.55 N/A	-495.66 -556%	-560.72 -13%	-1 052.22 -88%	-905.66 +14%	-466.33 +49%	-464.88 +0%	118.05 N/A	50.44 -57%	22.66 -55%	144.05 +536%	-385.11 N/A	-300 +22%	-232.38 +23%	-322 -39%	-330.16 -3%	-313.26 +5%	-384.42 -23%	-355.52 +8%	42.94 N/A	47.61 +11%	63 +32%	121.61 +93%	60.66 -50%	74.38 +23%	38.66 -48%	60.66 +57%	121.83 +101%	179.55 +47%	-190.16 N/A	-213.88 -12%	-264.5 -24%	-104.94 +60%	306 N/A	296.77 -3%	122.38 -59%	-102.55 N/A	-104.63 -2%	-97.51 +7%	-76.93 +21%	-14.42 +81%	39.26 N/A	71.37 +82%	175.58 +146%	116.31 -34%	-257.17 N/A	-457.2 -78%	-415.49 +9%	-319.26 +23%	17.84 N/A	201.75 +1 031%	255.64 +27%	211.66 -17%	313.02 +48%	350.49 +12%

Income Statement Balance Sheet Cash Flow Statement

Kukje Pharma Co Ltd
KRX:002720

Income Statement

Earnings Waterfall
Kukje Pharma Co Ltd

Income Statement
Kukje Pharma Co Ltd

See Also

Company

Help

Tools

Stocks

Kukje Pharma Co Ltd KRX:002720

Income Statement

Earnings Waterfall Kukje Pharma Co Ltd

Income Statement Kukje Pharma Co Ltd

See Also

Company

Help

Tools

Stocks

Kukje Pharma Co Ltd
KRX:002720

Earnings Waterfall
Kukje Pharma Co Ltd

Income Statement
Kukje Pharma Co Ltd